Average Co-Inventor Count = 6.37
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance Biopharma R&d Ip, LLC (22 from 262 patents)
2. Theravance, Inc. (18 from 386 patents)
3. Gilead Sciences, Inc. (17 from 910 patents)
4. Pliant Therapeutics, Inc. (7 from 15 patents)
64 patents:
1. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof
2. RE50554 - Amino acid compounds and methods of use
3. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
4. 12202842 - MCL1 inhibitors
5. 12187734 - Substituted pyridotriazine compounds and uses thereof
6. 12162844 - MCL-1 inhibitors
7. 12122776 - Tetracyclic compounds and uses thereof
8. 12054496 - Bridged tricyclic carbamoylpyridone compounds and uses thereof
9. 12024528 - Bridged tricyclic carbamoylpyridone compounds and uses thereof
10. 11897892 - Substituted pyridotriazine compounds and uses thereof
11. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease
12. 11697652 - Tetracyclic compounds and uses thereof
13. 11673887 - N-acyl amino acid compounds and methods of use
14. 11667652 - MCL1 inhibitors
15. 11643400 - MCL-1 inhibitors